Osaka, Japan

Masafumi Yoshimura


Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 25(Granted Patents)


Company Filing History:


Years Active: 1999

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Masafumi Yoshimura: Innovator in Glycosyltransferase Research

Introduction: Masafumi Yoshimura is a prominent inventor based in Osaka, Japan, known for his contributions to the field of molecular biology and biotechnology. With a total of two patents, his work focuses primarily on human glycosyltransferase, particularly in relation to cancer research.

Latest Patents: Yoshimura's latest patents revolve around the human glycosyltransferase gene (human GnT-III) and its applications. He has developed a recombinant DNA method for producing the enzyme, along with a cancerous metastasis inhibitor that comprises GnT-III or a gene thereof. This groundbreaking work provides methods for inhibiting cancerous metastasis in mammals, presenting potential therapeutic avenues for cancer treatment.

Career Highlights: Masafumi Yoshimura is associated with Takara Shuzo Co., Inc., a company well-regarded for its advancements in biotechnology and molecular research. His role has significantly impacted the development of innovative methods and compounds that have applications in the medical field.

Collaborations: Throughout his career, Yoshimura has collaborated with other esteemed researchers, including Atsushi Nishikawa and Yoshito Ihara. These partnerships have further enhanced his research efforts and contributed to innovative advancements in glycosyltransferase studies.

Conclusion: Masafumi Yoshimura's work exemplifies the innovative spirit of modern science, particularly in the realm of cancer research. His patents on human glycosyltransferase not only advance our understanding of molecular biology but also hold the potential for developing effective cancer therapies, marking him as a noteworthy inventor in the biotechnology sector.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…